Jean-Mathieu Beauregard
14PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Dec 09, 2022
Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.Jean-Mathieu Beauregard
|Aug 17, 2022
Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy.Alessandro Desy, Guillaume F Bouvet, Nancy Lafrenière
|Nov 27, 2021
Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry Rationale.Andreas Hallqvist, Johanna Svensson, Linn Hagmarker
|Oct 31, 2021
Quantitative SPECT (QSPECT) at high count rates with contemporary SPECT/CT systems.Alessandro Desy, Guillaume F Bouvet, Étienne Croteau
|Jan 13, 2021
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells.Rashmi G Shah, Marine A Merlin, Samuel Adant
|May 17, 2020
Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRT.Alessandro Desy, Guillaume F Bouvet, Andrea Frezza
Pageof 3
